These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26922834)

  • 1. Effect of preanalytical time-delay on platelet function as measured by multiplate, PFA-100 and VerifyNow.
    Jilma-Stohlawetz P; Ratzinger F; Schörgenhofer C; Jilma B; Quehenberger P
    Scand J Clin Lab Invest; 2016; 76(3):249-55. PubMed ID: 26922834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel.
    Geisler T; Booth J; Tavlaki E; Karathanos A; Müller K; Droppa M; Gawaz M; Yanez-Lopez M; Davidson SJ; Stables RH; Banya W; Zaman A; Flather M; Dalby M
    PLoS One; 2015; 10(8):e0135037. PubMed ID: 26317618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance.
    Tsantes A; Ikonomidis I; Papadakis I; Kottaridi C; Tsante A; Kalamara E; Kardoulaki A; Kopterides P; Kapsimali V; Karakitsos P; Lekakis J; Travlou A
    Platelets; 2012; 23(6):481-9. PubMed ID: 22646492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does measurement of platelet P-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy?
    Fox SC; May JA; Dovlatova N; Glenn JR; Johnson A; White AE; Radhakrishnan A; Heptinstall S
    Platelets; 2019; 30(3):290-295. PubMed ID: 29461906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients.
    Paniccia R; Antonucci E; Gori AM; Marcucci R; Giglioli C; Antoniucci D; Gensini GF; Abbate R; Prisco D
    J Thromb Haemost; 2007 Sep; 5(9):1839-47. PubMed ID: 17723123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
    Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
    Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
    Dyszkiewicz-Korpanty A; Olteanu H; Frenkel EP; Sarode R
    Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual antiplatelet response during PCI: VerifyNow P2Y12 predicts myocardial necrosis and thromboxane B2 generation confirms wide variation in aspirin response.
    Good RI; McGarrity A; James TE; Miller H; McConnachie A; Goodall AH; Oldroyd KG
    Thromb Res; 2015 Jun; 135(6):1140-6. PubMed ID: 25746368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrel.
    Bernlochner I; Morath T; Brown PB; Zhou C; Baker BA; Gupta N; Jakubowski JA; Winters KJ; Schömig A; Kastrati A; Sibbing D
    Platelets; 2013; 24(1):15-25. PubMed ID: 22372531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematocrit alters VerifyNow P2Y12 assay results independently of intrinsic platelet reactivity and clopidogrel responsiveness.
    Kakouros N; Kickler TS; Laws KM; Rade JJ
    J Thromb Haemost; 2013 Oct; 11(10):1814-22. PubMed ID: 24118870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to aspirin and clopidogrel monitored with different platelet function methods.
    Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
    Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D
    Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet effects of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on-treatment platelet reactivity.
    Alexopoulos D; Panagiotou A; Xanthopoulou I; Komninakis D; Kassimis G; Davlouros P; Fourtounas C; Goumenos D
    J Thromb Haemost; 2011 Dec; 9(12):2379-85. PubMed ID: 21985070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment.
    Paniccia R; Antonucci E; Gori AM; Marcucci R; Poli S; Romano E; Valente S; Giglioli C; Fedi S; Gensini GF; Abbate R; Prisco D
    Am J Clin Pathol; 2007 Jul; 128(1):143-9. PubMed ID: 17580282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
    Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
    Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel Resistance in Neurovascular Stenting: Correlations between Light Transmission Aggregometry, VerifyNow, and the Multiplate.
    Flechtenmacher N; Kämmerer F; Dittmer R; Budde U; Michels P; Röther J; Eckert B
    AJNR Am J Neuroradiol; 2015 Oct; 36(10):1953-8. PubMed ID: 26272977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of a low dosage of clopidogrel on platelet function in cats as measured by the platelet function analyser PFA-100 and the multiplate analyser.
    Teuber M; Mischke R
    Res Vet Sci; 2016 Dec; 109():149-156. PubMed ID: 27892864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) study.
    Tobin WO; Kinsella JA; Coughlan T; Collins DR; O'Neill D; Murphy RP; Egan B; Tierney S; Feeley TM; McCabe DJ
    Eur J Neurol; 2013 Feb; 20(2):344-52. PubMed ID: 22994699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate analyzer--comparison with two flow cytometric methods.
    Mueller T; Dieplinger B; Poelz W; Calatzis A; Haltmayer M
    Thromb Res; 2007; 121(2):249-58. PubMed ID: 17482663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.